Dr. Muhammad Taher A Al-Lozi, MD

Dr. Al-Lozi practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Al-Lozi's NPI, 1689690992, was assigned on July 14, 2006. Dr. Al-Lozi holds Missouri license R5P37.

Dr. Al-Lozi's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Al-Lozi also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Al-Lozi's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Al-Lozi is also affiliated with Barnes-Jewish West County Hospital. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Al-Lozi to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Al-Lozi practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Al-Lozi's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Al-Lozi is licensed in Missouri.

CMS data shows 1,128 Medicare services from Dr. Al-Lozi across 16 procedure codes in 2024, for 493 Medicare patients. Medicare paid $100,684 for them.

CMS counts 493 Medicare patients who saw Dr. Al-Lozi in 2024. The largest group is 65 to 74, with 259 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Al-Lozi's median patient age at 69, with 53% women.

In 2024, Dr. Al-Lozi wrote 379 Medicare Part D claims for 62 patients. 71% of them were for generic drugs. CMS names the drug for 265 of them, across 12 drugs with 11 or more claims each, at $856,094 in total drug cost. In 2023, CMS named 234 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Al-Lozi for performance year 2024, reported as part of a group. Dr. Al-Lozi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Al-Lozi to 1 clinical trial. Conditions studied include Myasthenia Gravis and Neuromuscular Junction Diseases. Open Payments lists research payments to Dr. Al-Lozi that name 1 trial.

CMS Open Payments shows 6 general payments to Dr. Al-Lozi from 3 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Natus Medical Incorporated paid the most, $393. It also lists 10 research payments totaling $3,712 from 2016 to 2019, naming 1 clinical trial.